Morgan Stanley’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$118M Buy
7,619,590
+1,917,066
+34% +$29.6M 0.01% 1191
2025
Q1
$84.8M Buy
5,702,524
+101,699
+2% +$1.51M 0.01% 1373
2024
Q4
$74.2M Buy
5,600,825
+245,928
+5% +$3.26M 0.01% 1483
2024
Q3
$76.1M Buy
5,354,897
+367,945
+7% +$5.23M 0.01% 1454
2024
Q2
$64.5M Sell
4,986,952
-8,671
-0.2% -$112K 0.01% 1509
2024
Q1
$69.4M Sell
4,995,623
-4,699,447
-48% -$65.3M 0.01% 1463
2023
Q4
$138M Buy
9,695,070
+4,461,789
+85% +$63.7M 0.01% 1412
2023
Q3
$81M Buy
5,233,281
+455,729
+10% +$7.05M 0.01% 1202
2023
Q2
$75.1M Buy
4,777,552
+197,001
+4% +$3.09M 0.01% 1265
2023
Q1
$75.5M Buy
4,580,551
+57,112
+1% +$941K 0.01% 1230
2022
Q4
$70.6M Sell
4,523,439
-99,568
-2% -$1.55M 0.01% 1247
2022
Q3
$60M Buy
4,623,007
+379,182
+9% +$4.92M 0.01% 1190
2022
Q2
$59.6M Buy
4,243,825
+3,920,647
+1,213% +$55M 0.01% 1253
2022
Q1
$4.63M Sell
323,178
-377,433
-54% -$5.4M ﹤0.01% 3773
2021
Q4
$9.55M Sell
700,611
-1,243,352
-64% -$16.9M ﹤0.01% 2996
2021
Q3
$31.8M Sell
1,943,963
-82,419
-4% -$1.35M ﹤0.01% 1649
2021
Q2
$34.1M Sell
2,026,382
-120,801
-6% -$2.03M ﹤0.01% 1614
2021
Q1
$39.2M Buy
2,147,183
+183,641
+9% +$3.35M 0.01% 1358
2020
Q4
$35.7M Sell
1,963,542
-54,776
-3% -$997K 0.01% 1343
2020
Q3
$36M Buy
2,018,318
+44,163
+2% +$788K 0.01% 1083
2020
Q2
$35.4M Buy
1,974,155
+398,173
+25% +$7.14M 0.01% 1038
2020
Q1
$23.9M Buy
1,575,982
+842,734
+115% +$12.8M 0.01% 1156
2019
Q4
$14.5M Buy
733,248
+161,005
+28% +$3.18M ﹤0.01% 1983
2019
Q3
$9.84M Sell
572,243
-882,166
-61% -$15.2M ﹤0.01% 2147
2019
Q2
$25.7M Buy
1,454,409
+163,572
+13% +$2.9M 0.01% 1299
2019
Q1
$26.3M Buy
1,290,837
+1,251,913
+3,216% +$25.5M 0.01% 1249
2018
Q4
$655K Buy
+38,924
New +$655K ﹤0.01% 4609